Insilico Medicine Signs Strategic Research Collaboration with ...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
New York , Nov. 8, 2022 /PRNewswire-AsiaNet/ -- Agreement includes aggregate upfront and target nomination fees of up to $21.5 million for up to 6 targets, and additional R&D and sales milestones plus tier-based mid-single- to low double-digit royalties.Insilico Medicine, a clinical s...
Authors: LATEST ASIANET NEWS RELEASES